焦虑抑郁症对抗抑郁药治疗反应的影响
Chantal Hampf1, Maike Scherf-Clavel1, Carolin Weiß1
1Department of Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, University Hospital of Würzburg, Margarete-Höppel-Platz 1, 97080 Würzburg, Germany.
International journal of molecular sciences
|December 23, 2023
概括
与非焦虑性抑郁症 (naMDD) 相比,焦虑性抑郁症 (aMDD) 最初没有显示出不同的治疗结果. 然而,aMDD患者在第7周经历了更糟糕的结果,特别是那些接受了venlafaxine治疗的人.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 临床心理学 临床心理学
背景情况:
- 焦虑性抑郁症 (aMDD) 是一种主要抑郁症亚型,与更糟糕的结果有关.
- 有限的研究存在于aMDD和非焦虑抑郁症 (naMDD) 患者之间的治疗差异.
- 调查治疗反应变化对于个性化抑郁症护理至关重要.
研究的目的:
- 为了比较aMDD与MMDD患者抗抑郁药疗法的有效性.
- 分析治疗剂量,血清度和药物特异性反应.
- 确定影响抑郁症患者与焦虑症状治疗结果的因素.
主要方法:
- 这是一项对346名患有严重抑郁症的患者进行的前性,自然主义研究.
- 在基线计算焦虑体化因子 (ASF).
- 治疗反应被定义为7周后HDRS-21得分减少≥50%.
- 根据抗抑郁药类型 (SSRI,SNRI,NaSSA,三环药物,组合药物) 进行子组分析.
主要成果:
- 基线ASF得分与整体治疗反应之间没有显著的关联.
- 在aMDD和MMDD患者之间,治疗结果没有初始差异.
- 非响应者表现出更高的ASF得分.
- 在第7周,aMDD患者的治疗结果比MMDD患者更差.
- 接受拉法辛治疗的aMDD患者在第7周表现明显较差.
结论:
- 虽然最初的治疗反应可能不会有差异,但焦虑抑郁症患者随着时间的推移会出现更糟糕的结果.
- 更高的焦虑体化与不响应抑郁症治疗有关.
- 文拉法辛在aMDD患者中可能效果较差.
- 需要进一步的随机对照试验来证实这些发现对于特定的精神药物.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
241
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
241
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
400
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
400
Antidepressant Drugs: Overview
507
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
507
Anxiolytic Drugs: Overview
322
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
322
Drug Therapy
45
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
45
Anxiolytic Drugs: Benzodiazepines and Buspirone
792
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
792


